← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 30, 2020Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2014
Nanjing Leads Biolabs Co.,Ltd— Founded
Drugs by trial phase (18 distinct, 15 trials)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (15)
- NCT07281976Lead sponsorPhase 1/Phase 2Dec 31, 2025
- NCT07042802Lead sponsorPhase 1/Phase 2Dec 10, 2025
- NCT07111546Lead sponsorPhase 2Oct 20, 2025
- NCT07099430Lead sponsorPhase 1/Phase 2Sep 5, 2025
- NCT06783647Lead sponsorPhase 2Feb 15, 2025
- NCT06157827Lead sponsorPhase 1/Phase 2Dec 5, 2023
- NCT06049290Lead sponsorPhase 1/Phase 2Oct 20, 2023
- NCT05779163Lead sponsorPhase 1/Phase 2Apr 14, 2023
- NCT05516914Lead sponsorPhase 1/Phase 2Sep 1, 2022
- NCT05223231Lead sponsorPhase 1/Phase 2Feb 24, 2022
- NCT05170958Lead sponsorPhase 1/Phase 2Jan 6, 2022
- NCT05042908Lead sponsorPhase 1Dec 31, 2021
- NCT05107011Lead sponsorPhase 1/Phase 2Dec 31, 2021
- NCT05102006Lead sponsorPhase 1/Phase 2Dec 22, 2021
- NCT04640545Lead sponsorPhase 1Dec 30, 2020
Details
- Founded
- Nanjing, CN Jun 1, 2014
- Last known activity
- Dec 31, 2025